Avaleht › Eesnäärmevähk › Kansas
Eesnäärmevähk kliinilised uuringud osariigis Kansas
22 uuringut haiguse Eesnäärmevähk jaoks otsivad osalejaid osariigis Kansas.
Linnad osariigis Kansas
- Kansas City12 uuringut
- Topeka7 uuringut
- Overland Park7 uuringut
- Olathe5 uuringut
- Lawrence3 uuringut
- Wichita3 uuringut
- Pittsburg3 uuringut
Ametlik uuringutekst (inglise keeles)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- ja veel 4
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 2. okt 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- ja veel 4
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 40–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- University of Kansas Cancer Center, Kansas City
- The University of Kansas Cancer Center - Olathe, Olathe
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- ja veel 2
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- ja veel 4
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT03866382DESTINY-PANTUMOUR04
- Research Site, Topeka
VärbamineVaatlusuuring
Vanused 18–130 · Kõik sood · Uuendatud 25. sept 2026 · NCT07124000Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- University of Kansas Hospital, Kansas City
VärbamineFaas 2/3
Vanused 18–100 · Mehed · Uuendatud 22. sept 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Kansas Medical Center, Westwood
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 22. sept 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- University of Kansas Hospital, Kansas City
VärbamineFaas 3
Vanused 18–100 · Mehed · Uuendatud 22. sept 2026 · NCT06855277A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- University of Kansas Medical Center, Kansas City
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 15. sept 2026 · NCT07581184Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Wichita Urology Group, Wichita
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 11. sept 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- University of Kansas Cancer Center, Kansas City
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- ja veel 3
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 10. sept 2026 · NCT05946213Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Kansas University Cancer Center, Kansas City
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 24. aug 2026 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- MidAmerica Cancer Care, Merriam
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 21. aug 2026 · NCT04221542Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Central Care Cancer Center - Garden City, Garden City
- Mercy Hospital Pittsburg, Pittsburg
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 19. aug 2026 · NCT04423211PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
- University of Kansas Medical Center, Kansas City
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 22. juuli 2026 · NCT06274047HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
- University of Kansas Health System, Kansas City
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. juuli 2026 · NCT03802851Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Instititute - South, Overland Park
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 19–110 · Kõik sood · Uuendatud 29. juuni 2026 · NCT02012699TERPS Trial for de Novo Oligometastic Prostate Cancer
- KU Medical Center- Cancer Center, Kansas City
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 3. juuni 2026 · NCT05223803Study of AZD0754 in Participants With Metastatic Prostate Cancer
- Research Site, Westwood
VärbamineFaas 1/2
Vanused 18–130 · Mehed · Uuendatud 23. veebr 2026 · NCT06267729A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Wichita Urology Group, Wichita
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 4. veebr 2026 · NCT04729114Vitamin D for Prostate Endocrine Therapy
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Health System Saint Francis Campus, Topeka
- ja veel 1
VärbamineFaas 3
Vanused 50 ja vanemad · Mehed · Uuendatud 15. jaan 2026 · NCT05838716Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- University of Kansas Cancer Center, Kansas City
- Olathe Health Cancer Center, Olathe
- University of Kansas Cancer Center-Overland Park, Overland Park
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 11. sept 2025 · NCT03678025Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.